Search

Author/Creator Shepard, Dale R.

1. A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. (6th June 2019)

Authors:
Michaelson, M. Dror; Gupta, Shilpa; Agarwal, Neeraj; Szmulewitz, Russell; Powles, Thomas; Pili, Roberto; Bruce, Justine Yang; Vaishampayan, Ulka; Larkin, James; Rosbrook, Brad; Wang, Erjian; Murphy, Danielle; Wang, Panpan; Lechuga, Maria Josè; Valota, Olga; Shepard, Dale R.
Journal:
Oncologist
Issue:
Volume 24:Number 9(2019)
Page Start:
1151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors. Issue 1 (4th December 2019)

Authors:
Cohen, Ezra E. W.; Pishvaian, Michael J.; Shepard, Dale R.; Wang, Ding; Weiss, Jared; Johnson, Melissa L.; Chung, Christine H.; Chen, Ying; Huang, Bo; Davis, Craig B.; Toffalorio, Francesca; Thall, Aron; Powell, Steven F.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database. (11th November 2018)

Authors:
Lawrenz, Joshua M.; Curtis, Gannon L.; Styron, Joseph F.; George, Jaiben; Anderson, Peter M.; Zahler, Stacey; Shepard, Dale R.; Rubin, Brian P.; Nystrom, Lukas M.; Mesko, Nathan W.
Other Names:
Kleinerman Eugenie S. Academic Editor.
Journal:
Sarcoma
Issue:
Volume 2018(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database. Issue 8 (27th June 2018)

Authors:
Curtis, Gannon L.; Lawrenz, Joshua M.; George, Jaiben; Styron, Joe F.; Scott, Jacob; Shah, Chirag; Shepard, Dale R.; Rubin, Brian; Nystrom, Lukas M.; Mesko, Nathan W.
Journal:
Journal of surgical oncology
Issue:
Volume 117:Issue 8(2018)
Page Start:
1776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Open‐label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment. Issue 6 (28th March 2019)

Authors:
Saif, Muhammad Wasif; Rosen, Lee; Rudek, Michelle A.; Sun, Weijing; Shepard, Dale R.; Becerra, Carlos; Yamashita, Fumiaki; Bebeau, Paul; Winkler, Robert
Journal:
British journal of clinical pharmacology
Issue:
Volume 85:Issue 6(2019)
Page Start:
1239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma. (5th May 2020)

Authors:
Lawrenz, Joshua M.; Featherall, Joseph; Curtis, Gannon L.; George, Jaiben; Jin, Yuxuan; Anderson, Peter M.; Shepard, Dale R.; Reith, John D.; Rubin, Brian P.; Nystrom, Lukas M.; Mesko, Nathan W.
Other Names:
Lewis Valerae O. Academic Editor.
Journal:
Sarcoma
Issue:
Volume 2020(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗